Abstract

IntroductionThe aim of this study was to evaluate the delayed chest closure (DCC) results in patients who underwent lung transplantation.MethodsSixty patients were evaluated retrospectively. Only bilateral lung transplantations and DCC for oversized lung allograft (OLA) were included in the study. Six patients who underwent single lung transplantation, four patients who underwent lobar transplantation, two patients who underwent retransplantation, and four patients who underwent DCC due to bleeding risk were excluded from the study. Forty-four patients were divided into groups as primary chest closure (PCC) (n=28) and DCC (n=16). Demographics, donor characteristics, and operative features and outcomes of the patients were compared.ResultsThe mean age was 44.5 years. There was no significant difference between the demographics of the groups (P>0.05). The donor/recipient predicted total lung capacity ratio was significantly higher in the DCC group than in the PCC group (1.06 vs. 0.96, P=0.008). Extubation time (4.3 vs. 3.1 days, P=0.002) and intensive care unit length of stay (7.6 vs. 5.2 days, P=0.016) were significantly higher in the DCC group than in the PCC group. In the DCC group, postoperative wound infection was significantly higher than in the PCC group (18.6% vs. 0%, P=0.19). Median survival was 14 months in all patients and there was no significant difference in survival between the groups (16 vs. 13 months, P=0.300).ConclusionDCC is a safe and effective method for the management of OLA in lung transplantation.

Highlights

  • The aim of this study was to evaluate the delayed chest closure (DCC) results in patients who underwent lung transplantation

  • The donor/recipient predicted total lung capacity ratio was significantly higher in the DCC group than in the primary chest closure (PCC) group (1.06 vs. 0.96, P=0.008)

  • In the DCC group, postoperative wound infection was significantly higher than in the PCC group (18.6% vs. 0%, P=0.19)

Read more

Summary

Introduction

The aim of this study was to evaluate the delayed chest closure (DCC) results in patients who underwent lung transplantation. Size matching is an important factor that directly affects the outcomes of lung transplantation. An oversized lung allograft (OLA) is defined as a donor/recipient predicted total lung capacity (pTLC) ratio > 1.0[1,2]. OLA identification can be used for any lung that does not fit into the thoracic cavity, with or without donor/recipient pTLC ratio > 1. The lungs are a highly susceptible organ and tend to be edematous, inflamed, and less compatible due to the effects of donor brain death, handling during procurement, cold storage, and ischemia-reperfusion injury[3]. The lung allograft may become oversized due to one or more of these factors

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call